MIV-150 + LNG ring

Product Overview

Alternative Name: MZCL Combination IVR

Development Status: Inactive

Target: Female

Mode: Hormonal

Delivery Type: Vaginal Ring

Duration Type: Long-acting

Description: MIV-150 (an NNRTI that targets HIV) with zinc acetate (an antiviral agent with activity against HIV and HSV-2), carrageenan (an antiviral agent with activity against HPV) and levonorgestrel (LNG, a progestin) in an EVA or silicone vaginal ring.

Updated date: May 30, 2018

Vertical Tabs


Project Phase: Early Development

Project Stage: Pre-clinical

Status Details:
  • Prototype macaque MZCL IVRs have undergone preclinical testing. Funding for human MZCL IVR development is currently being pursued.

Download Product Report